FMC Dialysis - Appleton is a medicare approved dialysis facility center in Appleton, Wisconsin and it has 19 dialysis stations. It is located in Outagamie county at 2701 N Oneida St, Ste E, Appleton, WI, 54911. You can reach out to the office of FMC Dialysis - Appleton at (920) 997-8600. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Dialysis - Appleton has the following ownership type - Profit. It was first certified by medicare in February, 2002. The medicare id for this facility is 522546 and it accepts patients under medicare ESRD program.
Name | FMC Dialysis - Appleton |
---|---|
Location | 2701 N Oneida St, Ste E, Appleton, Wisconsin |
No. of Dialysis Stations | 19 |
Medicare ID | 522546 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
2701 N Oneida St, Ste E, Appleton, Wisconsin, 54911 | |
(920) 997-8600 | |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
NPI Number | 1568493732 |
Organization Name | Fresenius Medical Care Appleton |
Doing Business As | Bio-medical Applications Of Wisconsin, Inc. |
Address | 2701 North Oneida St Appleton, Wisconsin, 54911 |
Phone Number | (920) 997-8600 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that nephrologists always communicated and cared for them. | 65% | 67% |
Patients who reported that nephrologists usually communicated and cared for them. | 24% | 15% |
Patients who reported that nephrologists sometimes or never communicated and cared for them. | 11% | 18% |
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 55% | 60% |
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 40% | 26% |
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 14% |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 58% | 62% |
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 33% | 20% |
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 9% | 18% |
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 55% | 62% |
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 41% | 26% |
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 4% | 12% |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 77% | 80% |
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 23% | 20% |
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 66% | 68% |
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 24% | 20% |
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 12% |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Dialysis patients with Hemoglobin data | 42 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 7 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 105 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 922 |
Percentage of adult patients getting regular hemodialysis at the center | 99 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Dialysis - Appleton with elevated calcium levels.
Patients with hypercalcemia | 109 |
Hypercalcemia patient months | 958 |
Patients with Serumphosphor | 111 |
Patients with Serumphosphor less than 3.5 mg/dL | 8 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 76 |
Patient months included in arterial venous fistula and catheter summaries | 575 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 67 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 75 |
Hospitalization Rate in facility | 168 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 303.2 |
Hospitalization Rate: Lower Confidence Limit | 96.1 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Dialysis - Appleton were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 23 (As Expected) |
Readmission Rate: Upper Confidence Limit | 36.2 |
Readmission Rate: Lower Confidence Limit | 13.1 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Dialysis - Appleton get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | .15 (Better than Expected) |
SIR: Upper Confidence Limit | .75 |
SIR: Lower Confidence Limit | .01 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Dialysis - Appleton's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 69 |
Transfusion Rate in facility | 33.1 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 88.2 |
Transfusion Rate: Lower Confidence Limit | 14 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC Dialysis - Appleton lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 426 |
Mortality Rate in facility | 22.6 (Worse than Expected) |
Mortality Rate: Upper Confidence Limit | 28.2 |
Mortality Rate: Lower Confidence Limit | 17.8 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago
FMC Dialysis - Appleton Location: 2701 N Oneida St, Ste E, Appleton, Wisconsin, 54911 Phone: (920) 997-8600 |
News Archive
Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.
Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.
Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia, the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.
"President Barack Obama has a standing invitation to speak at the [XIX International AIDS Conference in Washington, D.C., next week], and he likely would be welcomed with loud cheers given his progressive HIV/AIDS policies," journalist Jon Cohen writes in a Slate opinion piece.
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.
› Verified 3 days ago